Cas 267404-58-0,4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene

267404-58-0

Post Buying Request

Basic information

Product Name: 4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene
Synonyms: 4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene
CAS NO:267404-58-0
Molecular Formula:
Molecular Weight: 321.419
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene(CAS DataBase Reference)
NIST Chemistry Reference: 4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene(267404-58-0)
EPA Substance Registry System: 4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azaprop-1-yl)-cyclohex-1-ene(267404-58-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 267404-58-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

267404-58-0 Suppliers

Recommended suppliers

267404-58-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 267404-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,4,0 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 267404-58:
(8*2)+(7*6)+(6*7)+(5*4)+(4*0)+(3*4)+(2*5)+(1*8)=150
150 % 10 = 0
So 267404-58-0 is a valid CAS Registry Number.

267404-58-0Upstream product

267404-26-2 trans-1-(Methylsulfonyloxy)-4-phenyl-4-(3-(2-methoxyphenyl)-3-oxo-2-azapropyl)cyclohexane

267404-58-0Downstream Products

267404-58-0Relevant academic research and scientific papers

Fused heterocyclic compounds

-

Page/Page column 36, (2010/02/14)

A compound of formula I wherein m, n, A, B, D, E, G, H, Y, R1, R2, R3, R4, R5, and R8, are described herein.

Carbocyclic potassium channel inhibitors

-

, (2008/06/13)

The present invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 267404-58-0